NCT06485466
- Conditions
- Apatinib, Camrelizumab, Transarterial Chemoembolization, +1 more
- Locations
-
- Sichuan Cancer Hospital and Research Institute Chengdu, Sichuan, China
Clinical trial condition
Apatinib
Explore clinical trials studying Apatinib. Study availability and eligibility vary by location and protocol.
6 public trials
2 recruiting studies
Apatinib trial results
NCT05512481
- Conditions
- Acral Melanoma, Apatinib, Camrelizumab, +15 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
Not Yet Recruiting
A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer
NCT07031154
- Conditions
- Adebrelimab, Apatinib, Bronchial Neoplasms, +10 more
- Locations
-
- First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
Completed
DEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic Cholangiocarcinoma
NCT04834674
- Conditions
- Adenocarcinoma, Apatinib, Carcinoma, +7 more
- Locations
-
- Sichuan Cancer Hospital and Research Institute Chengdu, Sichuan, China
NCT03365765
- Conditions
- Apatinib
- Locations
-
- Huashan Hospital Affiliated to Fudan University Shanghai, China
NCT04188847
- Conditions
- Apatinib, Chemotherapy, Female Urogenital Diseases, +16 more
- Locations
-
- Lei Li Beijing, Beijing Municipality, China